CLARIVATE PLC (CLVT)

The company’s portfolio is built around curated databases and software tools that help users discover information, measure research impact, manage patents and trademarks, support drug development, and make evidence-based decisions. Well-known Clarivate assets include Web of Science, a major citation and research intelligence platform, and solutions connected to intellectual property management and life sciences intelligence.

Clarivate’s products are typically sold through subscriptions, recurring licences, and data-driven workflow offerings. This gives the business exposure to long-term demand for research analytics, patent information, academic discovery tools, and specialised content used by professionals who need authoritative sources rather than general search results.

The company has roots in the former intellectual property and science business of Thomson Reuters, which was separated and sold to private equity owners before Clarivate became a public company on the New York Stock Exchange in 2019. Its revenue base is geographically diversified, with the Americas representing the largest region and Europe, the Middle East, and Africa also contributing meaningfully.

Clarivate’s distinguishing feature is the combination of proprietary content, indexed data, and workflow software across several knowledge-intensive industries. Its performance is linked to institutional budgets, research activity, intellectual property filings, and demand for digital tools that make specialised information easier to search, analyse, and apply.